INDICATION AND LIMITATION OF USE

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

This site is intended for US healthcare professionals only.

IMPORTANT SAFETY INFORMATION

WARNING: ABUSE AND DEPENDENCE

  • CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Vyvanse is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in patients ages 6 and above. Vyvanse is not indicated or recommended for weight loss. Use of other sympathomimetic drugs for weight loss has been associated with serious cardiovascular adverse events. The safety and effectiveness of Vyvanse for the treatment of obesity have not been established.

IMPORTANT SAFETY INFORMATION    This site is intended for US healthcare professionals only.

WARNING: ABUSE AND DEPENDENCE

  • | CNS stimulants (amphetamines and methylphenidate-containing products), including Vyvanse, have a high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.
Full Safety Information Below

Tips to Help Assess for ADHD in Children and Adolescents

During an assessment of ADHD, it is important to assess a multitude of factors. A greater utilization of close-ended questions with young children, due to their inability to deal with the complexity of open-ended questions, may also help when employing the following steps.1-3

Tips for assessing children and adolescents with suspected ADHD4:

  1. Initiate: Screen for the possible presence of ADHD in individuals who present with inattention, hyperactivity, impulsivity, and academic or behavior problems.5,6
  2. Evaluate: Determine whether the patient meets the DSM-5® criteria for ADHD.5,6
  3. Assess: Interview parents and caregivers, as well as teachers and school professionals, regarding onset of core symptoms in various settings, the age of onset, the duration of symptoms, and the degree of functional impairment.5,6
  4. Obtain: Collect information about the patient’s family history, including ADHD and/or other significant mental disorders within the family, perinatal history, developmental milestones, medical history, and mental health history.5,6
  5. Exclude: Rule out alternative causes of symptoms, academic/work underachievement, or behavior problems.5,6

Diagnosis should be based on a complete history and evaluation of the patient.

You are about to leave vyvansepro.com.

Please be advised that Shire has no control over the content or presentation of the site you are about to view.

Cancel Continue